Conference
NETWORK META-ANALYSIS TO ASSESS THE RELATIVE EFFICACY AND SAFETY OF LINAGLIPTIN, EMPAGLIFLOZIN AND THE FIXED DOSE COMBINATION OF EMPAGLIFLOZIN AND LINAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
Authors
Daacke I; Kanters S; Thorlund K; Tebboth A
Volume
19
Pagination
pp. A667-A667
Publisher
ELSEVIER SCIENCE INC
Publication Date
November 1, 2016
Conference proceedings
VALUE IN HEALTH
Issue
7
ISSN
1098-3015